The Flow Cytometry market size in Middle-East Africa has been estimated at USD 413.64 Million in 2023. It is projected to reach USD 675.31 Million by 2028, at a CAGR of 10.3% during the forecast period.
Growing approvals for the flow cytometry methods in R&D and clinical trials is crucial for market growth. In addition, Y-o-Y growth in chronic diseases, advancements in stem cell research, and high throughput flow cytometry is projected to boost the market.
The growing number of mergers and acquisitions in flow cytometry techniques and increasing market proliferation in emerging countries will likely drive the Middle East and Africa. Moreover, technological developments, extensive product portfolio due to the novel product launches, and growing HIV and cancer patients are positively directing the growth levels of the market.
The availability of substitute methods and inexpensive techniques hamper the market. High costs associated with the flow cytometry and the cost of installation and maintenance are expensive, limiting this region's demand during the forecast period. The shortage of expert professionals also impedes the market. Lack of awareness about the capable advantages of flow cytometry restrains the need of this region.
This research report on the MEA Flow Cytometry market has been segmented and sub-segmented into the following categories:
Regionally, the market in this region is growing with high CAGR due to ongoing technological advancements, a huge patient base, and improving healthcare infrastructure, creating a wide range of opportunities for market players to expand their business in the untapped areas this region. The I is estimated to rule the MEA market during the assessment period. Improving healthcare amenities and introducing novel products relevant to the region's market increase the occurrence rate of diseases like cancer and HIV, accelerating the market. In addition, increasing steps are taken in immunology, and immune-oncology researchers are projected to foster the market.
The UAE flow cytometry market is witnessed to have significant growth in the market during the analysis period. The rise in the biotechnology sector is likely to foster the market. In addition, wide usage of applications among various fields, including cell culture, drug discovery, and stem cell therapy, accelerates the market during the analysis period.
KEY MARKET PLAYERS:
Companies such as Becton, Dickinson and Company, Beckman Coulter, Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Sysmex Partec GmbH, Luminex Corporation, Miltenyi Biotec GmbH, Bio-Rad Laboratories, Inc., Sony Biotechnology, Life Technologies Corporation Inc., EMD Millipore Corporation, Miltenyi Biotec, Thermo Fischer Scientific, Agilent Technologies, Inc., Affymetix Inc. are predicted to register the majority of the share of the MEA flow cytometry market during the forecast period.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com